
Liraglutide
CAS: 204656-20-2
Liraglutide is a research peptide in the glp-1 / weight management category. Liraglutide is a GLP-1 receptor agonist with 97% sequence homology to native human GLP-1. MiPeptidos offers Liraglutide in 3 sizes with 99.7% verified purity and full analytical documentation.
How Liraglutide Works
Liraglutide is a GLP-1 receptor agonist with 97% sequence homology to native human GLP-1. The palmitoyl fatty acid modification enables non-covalent albumin binding, which delays renal clearance and DPP-IV degradation. It stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and activates hypothalamic satiety centers to reduce food intake.
Research Applications
Pricing
| Size | Per Vial | 10-Pack |
|---|---|---|
5mg | $14.95 | $108.95 |
10mg | $57.95 | $422.95 |
30mgBest Value | $155.95 | $1137.95 |
Prices shown per vial from 10-pack. Volume discounts available for 50+ vials — contact us.
HPLC Purity Analysis
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every MiPeptidos order.
Reconstitution Calculator
Inject bacteriostatic water slowly along the vial wall. Gently swirl until dissolved — never shake. Store reconstituted solution at 2-8°C and use within 30 days.
Download Product Brochure
Get our detailed Liraglutide product brochure with specifications, research applications, HPLC analysis data, and reconstitution guide. Available in English and Spanish.
Customer Reviews
Frequently Asked Questions
Specifications
Sequence
31-amino acid GLP-1(7-37) analog with Arg34 substitution and C16 palmitoyl fatty acid chain attached to Lys26 via gamma-glutamic acid spacer
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides

Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.

Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for its effects on glucose metabolism and body weight regulation. One of the most researched peptides in the incretin class.

Retatrutide
A triple agonist targeting GIP, GLP-1, and glucagon receptors. Investigated in preclinical and clinical research for its multi-pathway approach to metabolic regulation.

Cagrilintide
A long-acting amylin analog researched for its effects on satiety signaling and energy balance. Often studied alongside GLP-1 agonists in combination protocols.